minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International / Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 4.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions
<MedicationAdministration xmlns="http://hl7.org/fhir">
<id value="cancer-related-medication-admin-doxorubicin-jenny-m"/>
<meta>
<profile
value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicationAdministration cancer-related-medication-admin-doxorubicin-jenny-m</b></p><a name="cancer-related-medication-admin-doxorubicin-jenny-m"> </a><a name="hccancer-related-medication-admin-doxorubicin-jenny-m"> </a><a name="cancer-related-medication-admin-doxorubicin-jenny-m-en-US"> </a><p><b>Normalization Basis Extension</b>: <span title="Codes:{http://snomed.info/sct 363804004}">Body weight characteristic (observable entity)</span></p><p><b>status</b>: Completed</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/medicationrequest-category outpatient}">Outpatient</span></p><p><b>medication</b>: <span title="Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 1790099}">10 ML doxorubicin hydrochloride 2 MG/ML Injection</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-jenny-m.html">Jenny M Female, DoB: 1965-01-01 ( Medical Record Number: MRN1234 (use: usual, ))</a></p><p><b>effective</b>: 2018-04-22</p><h3>Performers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Actor</b></td></tr><tr><td style="display: none">*</td><td><a href="Practitioner-us-core-practitioner-nancy-oncology-nurse.html">Practitioner Nancy Nurse </a></td></tr></table><p><b>reasonReference</b>: <a href="Condition-primary-cancer-condition-jenny-m.html">Condition Primary malignant neoplasm of female left breast (disorder)</a></p><p><b>request</b>: <a href="MedicationRequest-cancer-related-medication-request-doxorubicin-jenny-m.html">MedicationRequest: extension = Curative - procedure intent (qualifier value); status = active; intent = order; category = Outpatient; medication[x] = DOXOrubicin; authoredOn = 2018-04-12</a></p><p><b>note</b>: doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)</p><h3>Dosages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://snomed.info/sct 47625008}">Intravenous route (qualifier value)</span></td><td>105.96 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM codemg = 'mg')</span></td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-normalization-basis">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="363804004"/>
<display value="Body weight characteristic (observable entity)"/>
</coding>
</valueCodeableConcept>
</extension>
<status value="completed"/>
<category>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/medicationrequest-category"/>
<code value="outpatient"/>
</coding>
</category>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="1790099"/>
<display value="10 ML doxorubicin hydrochloride 2 MG/ML Injection"/>
</coding>
</medicationCodeableConcept>
<subject>🔗
<reference value="Patient/cancer-patient-jenny-m"/>
</subject>
<effectiveDateTime value="2018-04-22"/>
<performer>
<actor>🔗
<reference
value="Practitioner/us-core-practitioner-nancy-oncology-nurse"/>
</actor>
</performer>
<reasonReference>🔗
<reference value="Condition/primary-cancer-condition-jenny-m"/>
</reasonReference>
<request>🔗
<reference
value="MedicationRequest/cancer-related-medication-request-doxorubicin-jenny-m"/>
</request>
<note>
<authorReference>🔗
<reference
value="Practitioner/us-core-practitioner-nancy-oncology-nurse"/>
</authorReference>
<time value="2018-04-22"/>
<text
value="doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects."/>
</note>
<dosage>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous route (qualifier value)"/>
</coding>
</route>
<dose>
<value value="105.96"/>
<unit value="mg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</dose>
</dosage>
</MedicationAdministration>